Connect with others who understand.

Sign up Log in
Resources
About MyDepressionTeam
Powered By

Top 10 search results for "meditation dot dot dot" in Treatments. To see all results and access other features, sign up for free.

Erzofri ((Paliperidone Palmitate))

Overview
Erzofri, approved by the U.S. Food and Drug Administration (FDA), is an atypical (second-generation) antipsychotic drug used for treating schizophrenia in adults. People who are new to Erzofri or similar drugs…

read more

Abilify Maintena (Aripiprazole)

Overview
Abilify Maintena is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and the maintenance monotherapy (single-drug treatment) of bipolar 1 disorder in adults. This…

read more

Abilify (Aripiprazole)

Overview
Abilify is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, the acute treatment of manic and mixed episodes associated with bipolar 1 disorder, and as an adjunctive…

read more

Abilify Asimtufii (Aripiprazole)

Overview
Abilify Asimtufii is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and as a maintenance monotherapy (single-drug treatment) for bipolar 1 disorder in adults…

read more

Cobenfy (Xanomeline and Trospium Chloride)

Overview
Cobenfy is a combination medication of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia…

read more

Aplenzin (Bupropion Hydrobromide)

Overview

Aplenzin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD). Individuals may be prescribed Aplenzin for short-term or long-term treatment depending on…

read more

Wellbutrin XL (Bupropion Hydrochloride)

Overview

Wellbutrin XL is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) and for the prevention of seasonal affective disorder (SAD). For individuals with MDD…

read more

Forfivo XL (Bupropion Hydrochloride)

Overview

Forfivo XL is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in adults. Forfivo XL is not recommended as a starting treatment. It is intended for…

read more

Trazodone

Overview

Trazodone is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD). It is not recommended for children under 18 due to an increased risk of suicidal thoughts…

read more

Wellbutrin SR (Bupropion Hydrochloride)

Overview

Wellbutrin SR is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD). It is intended for use in adults and is not approved for children. Wellbutrin SR…

read more